{"schema_version":"secwatch.filing_event.v1","accession":"0001757898-25-000001","form_type":"8-K","ticker":"STE","cik":"0001757898","company_name":"STERIS plc","filed_at":"2025-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.744066+00:00","generated_at":"2026-05-27T02:47:45.684624+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"STERIS Q3 EPS $2.32 (+11% YoY); revenue $1.4B (+6%); guidance trimmed on currency","bullets":["Adjusted EPS of $2.32 vs $2.09 YoY; GAAP EPS $1.75 vs $1.49; revenue $1.4B (+6% as reported, +6% organic constant currency)","Healthcare revenue $976M (+7%); consumables +9%, service +13%, capital equipment -5%","AST revenue $258.1M (+10%); Life Sciences -7% to $136.4M on CECS divestiture and lower capital equipment","Fiscal 2025 outlook: revenue growth ~6% (prior 6.5-7.5%), adjusted EPS $9.05-$9.15 (from $9.05-$9.25), currency headwind ~$0.10","Nine-month free cash flow $588.1M vs $457.0M YoY; capex expected ~$360M"],"urls":{"canonical":"https://secwatch.observer/filing/0001757898-25-000001","json":"https://secwatch.observer/filing/0001757898-25-000001.json","markdown":"https://secwatch.observer/filing/0001757898-25-000001.md","text":"https://secwatch.observer/filing/0001757898-25-000001.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757898/000175789825000001/0001757898-25-000001-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757898/000175789825000001/ste-20250205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T02:47:45.684624+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}